Melbourne – October 21, 2026 -- Telix Manufacturing Solutions (TMS) runs seven facility groups across North America, Europe and Asia Pacific, anchored by 29 accredited radiopharmacies in the United States, to deliver radiopharmaceutical doses to patients before the products decay. The short half-life of these products makes efficient manufacturing and logistics a prerequisite for timely delivery.